nocodazole has been researched along with omega-n-methylarginine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catravas, JD; Jilling, T; Marczin, N; Papapetropoulos, A | 1 |
Beger, HG; Gansauge, F; Gansauge, S; Nussler, AK | 1 |
2 other study(ies) available for nocodazole and omega-n-methylarginine
Article | Year |
---|---|
Prevention of nitric oxide synthase induction in vascular smooth muscle cells by microtubule depolymerizing agents.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Colchicine; Cyclic GMP; Cytoskeleton; Enzyme Induction; In Vitro Techniques; Interleukin-1; Lipopolysaccharides; Microtubules; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroprusside; Nocodazole; omega-N-Methylarginine; Rats; Rats, Wistar | 1993 |
Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Topics: Apoptosis; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; G1 Phase; Humans; Interferon-gamma; Interleukin-1; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nocodazole; Nucleosomes; omega-N-Methylarginine; Pancreatic Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 1998 |